Seeing Is Believing
ACHL is currently covered by 4 analysts with an average price target of $6.7. This is a potential upside of $5.9 (737.5%) from yesterday's end of day stock price of $0.8.
Achilles Therapeutics PLC ADR's activity chart (see below) currently has 7 price targets and 17 ratings on display. The stock rating distribution of ACHL is 88.89% BUY and 11.11% SELL.
Highest price target for ACHL is $0.5, Lowest price target is $0.5, average price target is $6.7.
Most recent stock forecast was given by TAZEEN AHMAD from BAML on 14-Dec-2023. First documented stock forecast 26-Apr-2021.
Currently out of the existing stock ratings of ACHL, 8 are a BUY (88.89%), 1 are a SELL (11.11%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
0.5
$-0.7 (-58.33%)
20
4 months 4 days ago
0/2 (0%)
$-0.36 (-41.86%)
Buy
8 months 11 days ago
0/1 (0%)
$10.25 (61.19%)
Buy
10
1 years 4 months 11 days ago
0/4 (0%)
$7.44 (290.63%)
Buy
1 years 4 months 12 days ago
0/1 (0%)
$6.25 (37.31%)
What is ACHL (Achilles Therapeutics PLC ADR) average time for price targets to be met?
Which analyst has the current highest performing score on ACHL (Achilles Therapeutics PLC ADR) with a proven track record?
Which analyst has the current lower performing score on ACHL (Achilles Therapeutics PLC ADR) with a proven track record?
Which analyst has the most public recommendations on ACHL (Achilles Therapeutics PLC ADR)?
Which analyst is the currently most bullish on ACHL (Achilles Therapeutics PLC ADR)?
Which analyst is the currently most reserved on ACHL (Achilles Therapeutics PLC ADR)?